Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BMS1 ribosome biogenesis factor pseudogene 12 (BMS1P12) is a human pseudogene, meaning it is a region of DNA similar to the BMS1 ribosome biogenesis factor gene but is non-functional and does not encode a protein. It is listed as an approved pseudogene locus by the HUGO Gene Nomenclature Committee. Pseudogenes like BMS1P12 arise by gene duplication or retrotransposition but typically lack regulatory elements or coding potential, so they do not participate directly in cellular processes or disease. No evidence supports a physiological function, drug interaction, or therapeutic significance for BMS1P12. Key considerations: - Pseudogenes are generally excluded from lists of therapeutic targets. - No evidence of disease association, biomarker status, or direct biological function for BMS1P12 exists. - BMS1P12 should not be listed as a receptor, transporter, enzyme, or druggable target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BMS1 ribosome biogenesis factor pseudogene 12 (BMS1P12).